Kutanios
The coming revolution in skincare: LIPOXERASE™
London, United Kingdom · Founded 2017
- Headquarters
- London
- Employees
- 1–10
- Founded
- 2017
- Website
- kutanios.com
- Last Round
- SeedAug 2021
- Rounds
- 1
About
Kutanios is a London-based biotechnology startup developing novel lipid-based molecules to detoxify skin and protect against aging, cancer, acne, and environmental damage. The company's lead technology, LIPOXERASE, transfers the beneficial detoxification properties of HDL particles (good cholesterol) into topical skincare formulations, targeting the toxic lipid peroxide accumulation that drives skin aging and disorders. Founded in 2017 by Dr. Irina Miller and Norman Miller, Kutanios is an alumnus of the SOSV IndieBio NY accelerator program.
Summary
Kutanios is a Biotech company based in London, United Kingdom, founded in 2017. Its most recent funding was a Seed round in Aug 2021. Investors include SOSV.
Funding History
Aug 2021
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kutanios"><img src="https://indexed.vc/api/badge/company/kutanios" alt="Kutanios on Indexed.vc" width="260" height="76" /></a>